Simvastatin inhibits proliferation and induces apoptosis in human lung cancer cells

Oncology Research

Volumn 20, Issue 8, 2013, Pages 351-357

  Yu, Xiaofeng ^a   Pan, Yinghua ^a   Ma, Housheng ^a   Li, Wenjun ^a  

^a YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

Apoptosis; Cancer; Proliferation; Statins

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; PROTEIN BCL 2; SIMVASTATIN; X LINKED INHIBITOR OF APOPTOSIS;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL SURVIVAL; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84879623987     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504013X13657689382897     Document Type: Article

References (23)

1. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics, 2010. CA. Cancer. J. Clin. 60:277-300; 2010.
2. Molina, J. R.; Yang, P.; Cassivi, S. D.; Schild, S. E.; Adjei, A. A. Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship. Mayo Clin. Proc. 83:584-594; 2008.
3. Kones, R. Primary prevention of coronary heart disease: Integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des. Devel. Ther. 5:325-380; 2011.
4. Demierre, M. F.; Higgins, P. D.; Gruber, S. B.; Hawk, E.; Lippman, S. M. Statins and cancer prevention. Nat. Rev. Cancer 5:930-942; 2005.
5. Wong, W. W.; Dimitroulakos, J.; Minden, M. D.; Penn, L. Z. HMG-CoA reductase inhibitors and the malignant cell: The statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 16:508-519; 2002.
6. Miraglia, E.; Högberg, J.; Stenius, U. Statins exhibit anticancer effects through modifications of the pAkt signaling pathway. Int. J. Oncol. 40:867-875; 2012.
7. Kozar, K.; Kaminski, R.; Legat, M.; Kopec, M.; Nowis, D.; Skierski, J. S.; Koronkiewicz, M.; Jakóbisiak, M.; Golab, J. Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin. Int. J. Oncol. 24:1149-1157; 2004.
8. Coogan, P. F.; Smith, J.; Rosenberg, L. Statin use and risk of colorectal cancer. J. Natl. Cancer Inst. 99:32-40; 2007.
9. Platz, E. A.; Leitzmann, M. F.; Visvanathan, K.; Rimm, E. B.; Stampfer, M. J.; Willett, W. C.; Giovannucci, E. Statin drugs and risk of advanced prostate cancer. J Natl. Cancer Inst. 98:1819-1825; 2006.
10. Lee, K. J.; Moon, J. Y.; Choi, H. K.; Kim, H. O.; Hur, G. Y.; Jung, K. H.; Lee, S. Y,; Kim, J. H.; Shin, C.; Shim, J. J.; In, K. H.; Yoo, S. H.; Kang, K. H.; Lee, S. Y. Immune regulatory effects of simvastatin on regulatory T-cell-mediated tumour immune tolerance. Clin. Exp. Immunol. 161:298-305; 2010.
11. Hong, Y. S.; Ham, Y. A.; Choi, J. H.; Kim, J. Effects of allyl sulfur compounds and garlic extract on the expression of Bcl-2, Bax, and p53 in non-small cell lung cancer cell lines. Exp. Mol. Med. 32:127-134; 2000.
12. Matsuura, M.; Suzuki, T.; Suzuki, M.; Tanaka, R.; Ito, E.; Saito, T. Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma. Oncol. Rep. 25:41-47; 2011.
13. Martinou, J. C.; Youle, R. J. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev. Cell. 21:92-101; 2011.
14. Dong, Y.; Sui, L.; Sugimoto, K.; Tai, Y.; Tokuda, M. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas. Int. J. Cancer 95:209-215; 2001.
15. Pawar, S. A.; Sarkar, T. R.; Balamurugan, K.; Sharan, S.; Wang, J.; Zhang, Y.; Dowdy, S. F.; Huang, A. M.; Sterneck, E. C/EBPδ targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression. Proc. Natl. Acad. Sci. USA 107:9210-9215; 2010.
16. Sakamoto, K.; Ohki, K.; Saito, M.; Nakahara, T.; Ishii, K. Small molecule cyclin-dependent kinase inhibitors protect against neuronal cell death in the ischemic-reperfused rat retina. J. Ocul. Pharmacol. Ther. 27:419-425; 2011.
17. Ferri, K. F.; Kroemer, G. Organelle-specific initiation of cell death pathways. Nat. Cell. Biol. 3:E255-E263; 2001.
18. Fang, Y.; Elahi, A.; Denley, R. C.; Rao, P. H.; Brennan, M. F.; Jhanwar, S. C. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1. Anticancer Res. 29:1255-1262; 2009.
19. Dai, Y.; Qiao, L.; Chan, K. W.; Zou, B.; Ma, J.; Lan, H. Y.; Gu, Q.; Li, Z.; Wang, Y.; Wong, B. L.; Wong, B. C. Loss of XIAP sensitizes rosiglitazone-induced growth inhibition of colon cancer in vivo. Int. J. Cancer 122:2858-2863; 2008.
20. Sasaki, H.; Sheng, Y.; Kotsuji, F.; Tsang, B. K. Downregulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res. 60:5659-5666; 2000.
21. Mannello, F.; Tonti, G. A. Statins and breast cancer: May matrix metalloproteinase be the missing link. Cancer Invest. 27:466-470; 2009.
22. Wang, I. K.; Lin-Shiau, S. Y.; Lin, J. K. Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation. Oncology 59:245-254; 2000.
23. Wang, S.; Liu, Z.; Wang, L.; Zhang, X. NF-κB signaling pathway, inflammation and colorectal cancer. Cell. Mol. Immunol. 6:327-334; 2009.